Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.05 Analyst target: $30.00 Upside: 1363.41%
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily for the treatment of neuroinflammation. The company is headquartered in Jupiter, Florida.
See the full interactive analysis & chart →Informational only — not investment advice.